2.8800
-0.0140
(-0.48%)
As of 8:09:04 AM GMT+1. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.67M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KOENIG SCOTT Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Oct 7, 2024 |
| KOENIG SCOTT Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 23, 2024 |
| FERRANTE KAREN JEAN M.D. Director | -- | Direct | -- | May 20, 2024 |
| CHHABRA MEENU Director | -- | Direct | -- | May 20, 2024 |
| SIEGEL JAY PHILIP M.D. Director | -- | Direct | -- | May 20, 2024 |
| STUMP DAVID CARTER Director | -- | Direct | -- | May 20, 2024 |
| HURWITZ EDWARD Director | -- | Direct | -- | May 20, 2024 |
| O'BRIEN FEDERICA F Director | -- | Direct | -- | May 20, 2024 |
| HEIDEN WILLIAM K Director | -- | Direct | -- | May 20, 2024 |
| LIU MARGARET A Director | -- | Direct | -- | May 20, 2024 |
| JACKSON SCOTT THOMAS Director | -- | Direct | -- | May 20, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 15.07 - 18.22 per share. | Direct | 799,148 | Apr 4, 2024 |
| PETERS JEFFREY STUART General Counsel | Conversion of Exercise of derivative security at price 4.82 per share. | Direct | 204,850 | Apr 4, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 21.50 per share. | Direct | 421,938 | Mar 6, 2024 |
| PETERS JEFFREY STUART General Counsel | Conversion of Exercise of derivative security at price 10.15 - 11.50 per share. | Direct | 213,875 | Mar 6, 2024 |
| KARRELS JAMES Chief Financial Officer | Sale at price 20.50 per share. | Direct | 615,000 | Mar 4, 2024 |
| RISSER ERIC BLASIUS Chief Operating Officer | Sale at price 19.63 - 20.00 per share. | Direct | 813,501 | Mar 4, 2024 |
| SPITZNAGEL THOMAS Officer | Sale at price 20.00 per share. | Direct | 200,000 | Mar 4, 2024 |
| SPITZNAGEL THOMAS Officer | Conversion of Exercise of derivative security at price 11.50 per share. | Direct | 115,000 | Mar 4, 2024 |
| RISSER ERIC BLASIUS Chief Operating Officer | Conversion of Exercise of derivative security at price 10.15 per share. | Direct | 152,250 | Mar 4, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 17.22 per share. | Direct | 277,655 | Feb 26, 2024 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 22, 2024 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 22, 2024 |
| ECK STEPHEN L Officer | -- | Direct | -- | Feb 15, 2024 |
| SPITZNAGEL THOMAS Officer | -- | Direct | -- | Feb 15, 2024 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 15, 2024 |
| KARRELS JAMES Chief Financial Officer | -- | Direct | -- | Feb 15, 2024 |
| KOENIG SCOTT Chief Executive Officer | -- | Direct | -- | Feb 15, 2024 |
| CILINSKI LYNN Officer and Treasurer | -- | Direct | -- | Feb 15, 2024 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 15, 2024 |
| RISSER ERIC BLASIUS Chief Operating Officer | -- | Direct | -- | Feb 15, 2024 |
| BONVINI EZIO Officer | Sale at price 18.00 per share. | Direct | 60,012 | Feb 7, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 16.50 per share. | Direct | 1,258,142 | Feb 5, 2024 |
| PETERS JEFFREY STUART General Counsel | Conversion of Exercise of derivative security at price 10.15 - 11.50 per share. | Direct | 847,355 | Feb 5, 2024 |
| BONVINI EZIO Officer | Sale at price 15.00 per share. | Direct | 199,740 | Feb 1, 2024 |
| BONVINI EZIO Officer | Sale at price 12.00 per share. | Direct | 159,792 | Jan 19, 2024 |
| BONVINI EZIO Officer | Sale at price 10.08 per share. | Direct | 190,310 | Dec 20, 2023 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.46 per share. | Indirect | 669,585 | Oct 2, 2023 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.26 per share. | Direct | 1,052,840 | Sep 7, 2023 |
| HURWITZ EDWARD Director | Purchase at price 4.91 per share. | Direct | 73,650 | Aug 30, 2023 |
| PETERS JEFFREY STUART General Counsel | Sale at price 6.03 per share. | Direct | 32,393 | Mar 10, 2023 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 22, 2023 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 22, 2023 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.07 per share. | Indirect | 2,532,600 | Feb 14, 2023 |
Related Tickers
3G0.BE Altimmune Inc
6.78
+0.95%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
8AW0.BE Ocean Biomedical Inc
0.1910
+5.52%
1VT.DU Viking Therapeutics Inc
32.65
+1.56%
2UV.F Applied Therapeutics, Inc.
0.5470
+6.21%
2UV.DU Applied Therapeutics Inc
0.5720
-0.44%
AT20.F Atara Biotherapeutics, Inc.
8.05
+8.05%
8AW0.F Ocean Biomedical, Inc.
0.1710
-22.27%
0M4.DU Mersana Therapeutics Inc
0.6000
+1.59%
BX2.BE BioXcel Therapeutics Inc
0.3046
-2.09%